trending Market Intelligence /marketintelligence/en/news-insights/trending/Utv5ukTDszclEvqoHyR1Qw2 content esgSubNav
In This List

Acucela secures option to buy retinal technology

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Acucela secures option to buy retinal technology

Acucela Inc. secured an exclusive option to acquire EyeMedics LLC's proprietary retinal technology for the treatment of certain eye diseases.

While terms of the agreement were not disclosed, Acucela, a Kubota Pharmaceutical Holdings Co. Ltd. subsidiary, noted that the option was acquired under a research and development agreement with the company.